IDDO Logo
COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD)
10.48688/43zs-z633(2020)
In patients with suspected or confirmed 2019-nCoV who require admission to the intensive care unit mechanical ventilation and extracorporeal membrane oxygenation (ECMO). It is expected that this study will not require individual patient consent. This study is in effect a large-scale clinical audit during a global health emergency, as all data is already recorded as part of routine clinical care, therefore justifying participant enrolment using a waiver of consent. Retrospective data will be sourced from all collaborating hospitals across Australia from January 2020 to March 2020. Whereas, international hospitals will provide their retrospective data between January 2019 and march 2020. Prospective data will be collected in Australian and International hospitals until completion of COVID-19 global epidemic, as judged by the World Health Organization. The total duration of observation per participant will be until hospital discharge or 28 days post intensive care unit admission, whichever comes later. The study will combine prospective observation, and retrospective observations sourced from clinical charts.
DOI Created: Fri, 01 Oct 2021 20:54:10 GMT
DOI Updated: Thu, 24 Apr 2025 10:04:06 GMT
Prince Charles Hospital. (2020). COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD) [Data set]. the Infectious Diseases Data Observatory. https://doi.org/10.48688/43ZS-Z633